Dionigi Gianlorenzo, Lombardi Davide, Lombardi Celestino Pio, Carcoforo Paolo, Boniardi Marco, Innaro Nadia, Chiofalo Maria Grazia, Cavicchi Ottavio, Biondi Antonio, Basile Francesco, Zaccaroni Angelo, Mangano Alberto, Leotta Andrea, Lavazza Matteo, Calò Pietro Giorgio, Nicolosi Angelo, Castelnuovo Paolo, Nicolai Piero, Pezzullo Luciano, De Toma Giorgio, Bellantone Rocco, Sacco Rosario
1st Division of Surgery, Department of Surgical Sciences, Endocrine Surgery Research Center, University of Insubria (Varese-Como), Via Guicciardini, 21100, Varese, Italy.
Updates Surg. 2014 Dec;66(4):269-76. doi: 10.1007/s13304-014-0275-y. Epub 2014 Dec 3.
The frequency of neuromonitoring during thyroid surgery is underreported in Italy. The present survey depicts and describes the patterns of use, management, documentation for IONM devices of IONM during thyroid surgery by surgeons in Italy. A point prevalence survey was undertaken. Source data were mixed from Italian surgeons attending the 2014 International Neuromonitoring Study Group (INMSG) meeting, four IONM manufacturers available in Italy and surgical units were identified from Company sales data. Qualitative and quantitative data were used to analyze. Questions probed IONM prevalence, surgeon background, hospital geographic practice locations, type of hospital, rationale for IONM use, sources of initial capital investment for IONM acquisition, type of equipment, use of continuous IONM, monitoring management, use of distinctive standards, and IONM documentation. IONM is currently delivered through 48 units in Italy. In 2013, the distribution of IONM by specialties included: general (50 %), ENT (46 %), and thoracic surgery (4 %). Overall, 12.853 IONM procedures were performed in the period from 2006 to 2013: 253 were performed in 2007 and about 5,100 in 2013. Distribution according to the type of hospital is: public 48 %, academic setting 37 %, and private maintenance 15 %. The use category of high volume thyroid hospitals represented 33 %. Initial capital investment for the acquisition of the monitoring equipment was 67 % public and 33 % with charitable/private funding. Audio plus graphic and EMG electrodes surface endotracheal tube-based monitoring systems accounted for the majority. Continuous IONM was introduced in 5 Academic Centers. Overall motivations expressed are legal (30 %), RLN confirmation (20 %), RLN identification (20 %), prognosis (10 %), helpful in difficult cases (10 %), decrease surgical time (5 %), and educational (5 %). The survey revealed that participants had few experience with the standardized approach of IONM technique (28 %). General IONM information to patients and/or subsequent specific IONM informed consent was initiated in 8 % of centers. EMG determinations were included in medical chart in 20 %. There were no significant associations found between all parameters considered. The present study describes an increased utilization of IONM in Italy. We highlighted areas for improvement in the management and documentation of IONM.
在意大利,甲状腺手术期间神经监测的频率报告不足。本次调查描绘并描述了意大利外科医生在甲状腺手术中使用、管理和记录神经监测设备的模式。进行了一项现况调查。源数据来自参加2014年国际神经监测研究小组(INMSG)会议的意大利外科医生、意大利现有的四家神经监测设备制造商,以及从公司销售数据中识别出的手术科室。使用定性和定量数据进行分析。问题涉及神经监测设备的普及率、外科医生背景、医院地理位置、医院类型、使用神经监测设备的理由、购置神经监测设备的初始资本投资来源、设备类型、连续神经监测的使用、监测管理、独特标准的使用以及神经监测设备的记录。目前意大利有48个单位配备了神经监测设备。2013年,按专科划分的神经监测设备分布情况为:普通外科(50%)、耳鼻喉科(46%)和胸外科(4%)。总体而言,2006年至2013年期间共进行了12853例神经监测手术:2007年进行了253例,2013年约为5100例。按医院类型划分的分布情况为:公立48%、学术机构37%、私立15%。高容量甲状腺医院的使用类别占33%。购置监测设备的初始资本投资中,67%来自公共资金,33%来自慈善/私人资金。音频加图形和肌电图电极基于表面气管插管的监测系统占多数。5个学术中心引入了连续神经监测。表达的总体动机包括法律方面(30%)、喉返神经确认(20%)、喉返神经识别(20%)、预后(10%)、对困难病例有帮助(10%)、缩短手术时间(5%)和教育方面(5%)。调查显示,参与者对神经监测技术标准化方法经验较少(28%)。8%的中心向患者提供了一般神经监测信息和/或随后的特定神经监测知情同意书。20%的医疗记录中包含肌电图测定。在所考虑的所有参数之间未发现显著关联。本研究描述了意大利神经监测设备使用的增加。我们强调了神经监测设备管理和记录方面有待改进的领域。